Affimed to Present at Upcoming Investor Conferences
November 04 2020 - 6:30AM
Heidelberg, Germany, November 4,
2020 – Affimed N.V. (Nasdaq: AFMD), a clinical-stage
immuno-oncology company committed to giving patients back their
innate ability to fight cancer, today announced that the company’s
management will participate in the following investor conferences
during the month of November:
Jefferies Virtual London Healthcare
Conference (November 17-19, 2020) Presentation date:
Tuesday, November 17, 2020Presentation time: 12:20 p.m. GMT (7:20
a.m. EST)
SVB Leerink Oncology 1x1 Day (November
19, 2020) Affimed will host meetings with investors at the
conference
A live webcast of the Jefferies Healthcare
Conference presentation will be accessible on Affimed’s website at
https://www.affimed.com/investors/webcasts_cp/. A replay of the
call will be archived on Affimed’s website for 30 days after the
call.
For more information on the conferences or to
schedule a one-on-one meeting with Affimed management, please
contact your conference representative or Alex Fudukidis via email
at a.fudukidis@affimed.com or phone at +1 (917) 436-8102.
About Affimed N.V.
Affimed (Nasdaq: AFMD) is a clinical-stage immuno-oncology
company committed to giving patients back their innate ability to
fight cancer. Affimed’s fit-for-purpose ROCK® platform allows
innate cell engagers to be designed for specific patient
populations. The company is developing single and combination
therapies to treat hematologic and solid tumors. The company is
currently enrolling patients into a registration-directed study of
AFM13 for CD30-positive relapsed/refractory peripheral T cell
lymphoma and into a Phase 1/2a dose escalation/expansion study of
AFM24 for the treatment of advanced EGFR-expressing solid tumors.
For more information, please visit www.affimed.com.
Affimed Investor ContactAlexander Fudukidis
Head of Investor RelationsE-Mail:
a.fudukidis@affimed.comTel.: +1 (917) 436-8102
Affimed NV (NASDAQ:AFMD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Affimed NV (NASDAQ:AFMD)
Historical Stock Chart
From Sep 2023 to Sep 2024